Sugi Predict

Sugi Predict / Compounds / SCHEMBL1005537

SCHEMBL1005537

SCHEMBL1005537

CC(=O)C(N)(CN)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ GRM2 Q14416 1/20 0.32
▸ GRM3 Q14832 1/20 0.32
▸ ARG1 P05089 1/20 0.32
▸ ARG2 P78540 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ GGT1 P19440 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ GLRA1 P23415 1/20 0.32
▸ SLC6A9 P48067 1/20 0.32
▸ OR51E2 Q9H255 1/20 0.32
▸ ODC1 P11926 2/20 0.31
▸ TSHR P16473 1/20 0.30
▸ FFAR3 O14843 1/20 0.30
▸ LCK P06239 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL283186 0.86 KDM4E (0.35) KDM4EALDH1A1GLRA1SLC6A9OR51E2
SCHEMBL825611 0.83 SMN1; SMN2 (0.42) SMN1; SMN2HIF1AKDM4EARG1ARG2
SCHEMBL28792659 0.80 ODC1 (0.38) SMN1; SMN2HIF1AKDM4EARG1ARG2
SCHEMBL20636765 0.80 ODC1 (0.38) SMN1; SMN2HIF1AKDM4EARG1ARG2
SCHEMBL7253604 0.79 ALDH1A1 (0.41) SMN1; SMN2HIF1AGRM2GRM3ARG1
SCHEMBL31296136 0.79 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AARG1ARG2ALDH1A1
SCHEMBL22612007 0.77 HIF1A (0.44) SMN1; SMN2HIF1AKDM4EALDH1A1GGT1
SCHEMBL766735 0.77 SMN1; SMN2 (0.35) SMN1; SMN2HIF1AKDM4EALDH1A1GGT1
SCHEMBL11872169 0.77 HIF1A (0.44) SMN1; SMN2HIF1AKDM4EALDH1A1GGT1
SCHEMBL766734 0.77 SMN1; SMN2 (0.35) SMN1; SMN2HIF1AKDM4EALDH1A1GGT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212890-A1 METASTIN DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-09-01 — — US claimed
US-20110118172-A1 METASTIN DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-19 — — US claimed
EP-2314609-A1 METASTIN DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2011-04-27 — — EP claimed
JP-4653840-B2 — — 2011-03-16 — — JP claimed
US-20110059888-A1 METASTIN DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-03-10 — — US claimed
EP-2277900-A1 METASTIN DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2011-01-26 — — EP claimed
US-20090298765-A1 Metastin derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-03 — — US claimed
EP-2113513-A2 Metastin derivatives and use thereof Takeda Pharmaceutical Company Limited (JP) 2009-11-04 — — EP claimed
US-20090215700-A1 Metastin derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-08-27 — — US claimed
EP-2081955-A1 METASTIN DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-29 — — EP claimed
JP-2009520682-A — — 2009-05-28 — — JP claimed
US-20090105152-A1 METASTIN DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-23 — — US claimed
US-20080312155-A1 Metastin Derivatives and Use Thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 — — US claimed
EP-1963362-A1 METASTIN DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2008-09-03 — — EP claimed
WO-2008050897-A1 METASTIN DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-02 — — WO claimed
WO-2007072997-A1 METASTIN DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 — — WO claimed
CN-114432423-A NF for treating diseases and disorderskInhibitors of B activity 拉金德拉·萨哈伊·巴特纳格尔 2022-05-06 — — CN disclosed
US-20200188476-A1 ANTI-MICROBIAL AGENT-POLYMER CONJUGATES AND METHODS OF USE THEREOF UNIV CALIFORNIA (US) 2020-06-18 — — US disclosed
US-20040116336-A1 Peptide derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-06-17 — — US disclosed
EP-1270585-A1 PEPTIDE DERIVATIVE Takeda Chemical Industries, Ltd. (JP) 2003-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215700-A1 Metastin derivatives and use thereof SHBG, GNRHR, INHA SMN1; SMN2 2768/4885HIF1A 2197/4885KDM4E 4035/4885
US-20080312155-A1 Metastin Derivatives and Use Thereof GNRHR, SHBG, MEN1 SMN1; SMN2 3065/4885HIF1A 1660/4885KDM4E 3215/4885
US-20110059888-A1 METASTIN DERIVATIVES AND USE THEREOF SHBG, GNRHR, INHA SMN1; SMN2 2768/4885HIF1A 2197/4885KDM4E 4035/4885
US-20200188476-A1 ANTI-MICROBIAL AGENT-POLYMER CONJUGATES AND METHODS OF USE THEREOF DDOST, MGAM, MSN SMN1; SMN2 3880/4885HIF1A 2612/4885KDM4E 3749/4885
US-20110118172-A1 METASTIN DERIVATIVE AND USE THEREOF GNRHR, SHBG, INHA SMN1; SMN2 2827/4885HIF1A 2357/4885KDM4E 3328/4885
US-20090298765-A1 Metastin derivatives and use thereof GNRHR, SHBG, MEN1 SMN1; SMN2 3065/4885HIF1A 1660/4885KDM4E 3215/4885
US-20110212890-A1 METASTIN DERIVATIVE AND USE THEREOF GNRHR, SHBG, LHCGR SMN1; SMN2 3461/4885HIF1A 2690/4885KDM4E 3731/4885
US-20090105152-A1 METASTIN DERIVATIVES AND USE THEREOF SHBG, GNRHR, INHA SMN1; SMN2 2775/4885HIF1A 2068/4885KDM4E 3876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.